Research

Blood Cancer Clinical Trials

The following clinical trials related to blood cancers are available through the WPAHS. Please click on the link for more detailed information on the trial. Below each trial is the contact information at the WPAHS.

Leukemia Trials

Acute Myelogenous Leukemia (AML)

Study Title

A Phase III Randomized, Double-Blind Study of Induction (Daunorubicin/Cytarabine) and Consolidation (High-Dose Cytarabine) Chemotherapy + Midostaurin (PKC412) (IND #101261) or Placebo in Newly Diagnosed Patients < 60 Years of Age With FLT3 Mutated Acute Myeloid Leukemia (AML)

Principal Investigator: John Lister, M.D.

Please also contact study coordinator for more information:

Rich Wonder, RN, CCRC (Phone 412.578.4492)

Laura Gibson, RN, CCRC (Phone 412.578.4439)

Internal Reference: (IRB 08-09-051-JL/CALGB 10603 Lister)

Lymphoma Trials

Hodgkin Lymphoma (HL)

Study Title

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study in the Treatment of Patients At High Risk of Residual Hodgkin Lymphoma (HL) Following Autologous Stem Cell Transplant (ASCT)

Principal Investigator: James Rossetti D.O.

Please also contact study coordinator for more information:

Laura Gibson, RN, CCRC (Phone 412.578.4439)

Internal Reference: (09-044/ Rossetti)

Non-Hodgkin Lymphoma (NHL)

Diffuse Large B-Cell

Study Title

Phase III Randomized Study of R-CHOP V. Dose-Adjusted EPOCH-R With Molecular Profiling in Untreated De Novo Diffuse Large B-Cell Lymphomas

Principal Investigator: John Lister, M.D.

Please also contact study coordinator for more information:

Rich Wonder, RN, CCRC (Phone 412.578.4492)

Internal Reference: (IRB 06-10-057-RS/CALGB 50303 Lister)